NASDAQ:ONCS - OncoSec Medical Incorporated
$0.58
 $-0.01
-1.02%
4:00PM EDT
2019-04-18
OncoSec Medical Incorporated is a biotechnology company. The Company is focused on designing, developing and commercializing gene therapies, therapeutics and medical approaches to stimulate an anti-tumor immune response for the treatment of cancer. The Company's lead product candidate, ImmunoPulse IL-12, consists of a plasmid construct encoding the proinflammatory cytokine, IL-12, which is delivered into the tumor through in vivo electroporation. As of July 31, 2016, the Company was pursuing two Phase II trials: ImmunoPulse IL-12 monotherapy in patients with metastatic melanoma and ImmunoPulse IL-12 plus pembrolizumab in patients with advanced, metastatic melanoma. In addition, it is pursuing ImmunoPulse IL-12 monotherapy in patients with triple negative breast cancer. Its ImmunoPulse product candidates are based on its deoxyribonucleic acid (DNA)-based immunotherapy technology, which is designed to stimulate the human immune system, resulting in systemic anti-tumor immune responses. Read more at  reuters.com
sector:  health care
industry:  biotechnology
the data below are updated and published after 9pm EDT each trading day
  ONCS     avg for
industry  
  avg for
sector  
42 stocks weight:  0. 59   199. 07   233. 87  
42 stocks rank:  3. 77 K 1. 43 K 1. 06 K
# analyst opinions:  2. 00   14. 48   14. 09  
mean recommendation:  2. 30   2. 09   2. 01  

quick ratio:  4. 39   5. 29   1. 92  
current ratio:  4. 69   5. 64   2. 40  

target price low:  0. 40   84. 50   115. 74  
target price avg:  0. 50   110. 73   137. 39  
target price high:  0. 95   136. 41   157. 80  
1-yr high:  1. 91   114. 11   138. 85  
last close:  0. 58   87. 56   116. 78  
50-day avg:  0. 58   95. 43   123. 53  
200-day avg:  1. 03   94. 13   121. 20  
1-yr low:  0. 48   72. 67   98. 41  
volume:  285. 62 K 2. 43 M 4. 85 M
50-day avg volume:  582. 70 K 2. 72 M 4. 97 M
200-day avg volume:  1. 16 M 2. 90 M 4. 58 M

1-day return:  -1. 69 % -0. 40 % 0. 07 %
this week return:  -10. 77 % -5. 72 % -4. 11 %
12-wk return:  -19. 44 % 1. 78 % -0. 04 %
52-wk return:  -60. 43 % 10. 81 % 14. 09 %

enterprise value (EV):  12. 80 M 51. 19 B 117. 96 B
market cap:  37. 59 M 43. 00 B 104. 52 B
EBITDA:  -37. 21 M 4. 45 B 8. 01 B
enterprise multiple (EV/EBITDA):  -0. 34   4. 34   13. 27  
total debt:  0. 00   12. 22 B 16. 66 B
net income (common):  -38. 39 M 2. 20 B 4. 21 B

shares outstanding:  64. 81 M 570. 91 M 1. 24 B
shares:  52. 69 M 571. 02 M 1. 23 B
shares short:  2. 85 M 9. 93 M 16. 79 M
shares short prior month:  3. 35 M 9. 96 M 16. 58 M
short ratio:  7. 01   5. 31   3. 30  
short % of float:  4. 85 % 5. 81 % 2. 61 %
total cash/share:  0. 44   11. 13   9. 30  
total cash:  28. 73 M 6. 70 B 7. 10 B
free cash flow:  -9. 37 M 3. 58 B 4. 74 B
operating cash flow:  -25. 24 M 4. 14 B 6. 32 B

book value:  0. 38   12. 76   26. 84  
price/book:  1. 52   3. 08   -1. 74  
operating margins:  0. 00 % -721. 97 % -88. 82 %
EBITDA margins:  0. 00 % 10. 94 % 22. 54 %
profit margins:  0. 00 % 7. 81 % 10. 60 %
gross margins:  0. 00 % 37. 02 % 55. 68 %

1-yr max volatility:  -50. 00 % --- ---
1-yr mean volatility:  -0. 24 % 0. 03 % 0. 04 %

1-yr EPS:  -0. 69   2. 39   4. 08  
forward EPS:  -0. 61   3. 97   7. 14  
P/E:  -0. 84   13. 59   22. 83  
forward P/E:  -1. 07   -20. 05   14. 49  
PE/G:  0. 02   -1. 46   1. 68  
growth:  -49. 31 % 126. 81 % 29. 29 %
earnings high:  -0. 14   1. 02   1. 63  
earnings avg:  -0. 14   0. 76   1. 51  
earnings low:  -0. 14   0. 47   1. 39  
revenue high:  -0. 00   2. 68 B 10. 71 B
revenue avg:  -0. 00   2. 59 B 10. 49 B
revenue low:  -0. 00   2. 49 B 10. 25 B
return on assets:  -86. 20 % -2. 80 % 5. 29 %
return on equity:  -179. 81 % -18. 52 % 7. 38 %

beta (1yr vs S&P500):  0. 76   1. 24   0. 93  
sharpe (1yr):  -0. 66   0. 29   0. 60  

held % insiders:  18. 21 % 6. 38 % 3. 38 %
held % institutions:  6. 40 % 78. 60 % 68. 65 %

Research more with google or yahoo!
the data below are updated and published after 9pm EDT each trading day

2019-04-19 : ONCS
.    + 0.068 =         0.068 :: INITIAL WEIGHT
.   + 29.741 =        29.808 :: spline projection addition
.    x 1.432 =        42.686 :: industry recommendation factor
.    x 1.784 =        76.134 :: symbol recommendation factor
.    x 0.991 =        75.478 :: return on assets factor
.    x 0.982 =        74.121 :: return on equity factor
.    x 2.832 =       209.947 :: current ratio factor
.    x 1.138 =       238.914 :: quick ratio factor
.    x 1.069 =       255.387 :: short ratio factor
.    x 2.015 =       514.652 :: price-to-book factor
.     x 1.06 =       545.573 :: 5-day avg > 50-day avg
.    x 2.163 =      1180.256 :: P/E weight
.    x 2.209 =      2607.138 :: PE/G factor
.    x 1.526 =      3977.236 :: beta factor
.    x 0.665 =      2643.237 :: sharpe factor
.    x 0.944 =      2495.986 :: target low factor
.    x 0.934 =      2331.682 :: target mean factor
.     x 1.08 =      2519.151 :: target high factor
.    x 1.312 =      3304.241 :: industry 2-weeks return factor
.     x 0.89 =      2940.436 :: "drift" penalty 3 days ago
.    x 0.891 =      2618.476 :: overall "drift" factor
.    x 0.998 =      2612.182 :: largest single-day jump factor
.     x 0.06 =        157.36 :: low price factor
.      x 1.0 =       157.335 :: factor hist industry gain for week 15
.   cubeRoot =         5.399 :: reduced to standardize
.   - 25.433 =         0.587 :: add/subtract for performance
.                      0.587 :: FINAL WEIGHT for NASDAQ:ONCS


 


News feed RSS items generated from finance.google.com

News feed formatting by feed2js.org